Khaled Musallam/LinkedIn
Sep 2, 2026, 14:28
Khaled Musallam: The 5th MENA Congress for Rare Diseases Is Coming to Abu Dhabi
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to the 5th MENA Congress for Rare Diseases, taking place 3–5 September in Abu Dhabi.
Pleased to contribute across three exciting areas – chairing the 2nd MENA Summit for Gene and Cell Therapy, chairing and speaking in the rare immune and blood disorders session, and chairing AI, research, and innovation in rare diseases.
Three days bringing together science, innovation, and collaboration to advance care for people living with rare diseases.”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Sep 2, 2026, 14:21Christopher C. Young: MMA Embolization Shows Promise for Cancer Patients With Chronic Subdural Hematoma
-
Sep 2, 2026, 14:07Faheema Hasan: A New Second-Line Therapy for Essential Thrombocythemia
-
Sep 2, 2026, 14:05Andrew Kuykendall: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 2, 2026, 13:50Yazhini Selvaraj: Cold Agglutination in Cardiopulmonary Bypass
-
Sep 2, 2026, 09:52Rick Matthews: Expanding Mechanical Thrombectomy to Coronary Arteries
-
Sep 2, 2026, 09:49Yara Dixon: Barriers and Facilitators to Blood Donation Across Diverse Populations
-
Sep 2, 2026, 09:29Ana Sachetto: Liver Injury and Tissue Factor-Driven Coagulation
-
Sep 2, 2026, 09:28Kavya Keerthana: A Potentially Important Advance in Polycythemia Vera
-
Sep 2, 2026, 09:26Mohammad Zuryan: Pre-Marital Genetic Screening for Thalassemia Prevention